| Metric | FY 2025 | Prior Q | FY 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $138.2B | — | — | — | — |
| Op. Income | $29.3B | — | — | — | — |
| Gross Margin | 45.6% | — | — | — | — |
| Net Margin | 12.4% | — | — | — | — |
| EPS (Diluted) | $4.06 | — | — | — | — |
| Free Cash Flow | $20.1B | — | — | — | — |
| Item | Amount |
|---|---|
| REVENUE | $138.2B |
| Cost of Revenue | $75.1B |
| GROSS PROFIT | $63.1B |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $33.8B |
| Other Expenses | $0 |
| Operating Expenses | $33.8B |
| Cost & Expenses | $108.9B |
| OPERATING INCOME | $29.3B |
| Interest Income | $0 |
| Interest Expense | $6.7B |
| Other Income/Expenses | -$6.6B |
| INCOME BEFORE TAX | $22.7B |
| Income Tax Expense | $5.1B |
| Net Income from Continuing Ops | $17.6B |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $17.2B |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $17.2B |
| D&A | $18.3B |
| EBIT | $29.4B |
| EBITDA | $47.7B |
| EPS | $4 |
| EPS Diluted | $4 |
| Item | Amount |
|---|---|
| REVENUE | $138.2B |
| Cost of Revenue | $75.1B |
| GROSS PROFIT | $63.1B |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $33.8B |
| Other Expenses | $0 |
| Operating Expenses | $33.8B |
| Cost & Expenses | $108.9B |
| OPERATING INCOME | $29.3B |
| Interest Income | $0 |
| Interest Expense | $6.7B |
| Other Income/Expenses | -$6.6B |
| INCOME BEFORE TAX | $22.7B |
| Income Tax Expense | $5.1B |
| Net Income from Continuing Ops | $17.6B |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $17.2B |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $17.2B |
| D&A | $18.3B |
| EBIT | $29.4B |
| EBITDA | $47.7B |
| EPS | $4 |
| EPS Diluted | $4 |
| Item | Amount |
|---|---|
| Net Income | $17.2B |
| Depreciation & Amortization | $18.3B |
| Stock-Based Compensation | $0 |
| Deferred Income Tax | $2.3B |
| Other Non-Cash Items | $1.6B |
| Change in Working Capital | -$2.3B |
| OPERATING CASH FLOW | $37.1B |
| Capital Expenditure | -$17.0B |
| Acquisitions (Net) | $0 |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | $801M |
| NET CASH FROM INVESTING | -$16.7B |
| Net Debt Issuance | $7.8B |
| Common Stock Repurchased | $0 |
| Common Dividends Paid | -$11.5B |
| Other Financing Activities | -$1.9B |
| NET CASH FROM FINANCING | -$5.6B |
| FREE CASH FLOW | $20.1B |
| Net Change in Cash | $14.5B |
| Item | Amount |
|---|---|
| Cash & Equivalents | $19.0B |
| Short-Term Investments | $0 |
| Net Receivables | $28.3B |
| Inventory | $2.4B |
| Other Current Assets | $7.1B |
| TOTAL CURRENT ASSETS | $56.9B |
| PP&E (Net) | $133.0B |
| Goodwill | $22.8B |
| Intangible Assets | $10.5B |
| Long-Term Investments | $785M |
| Tax Assets | $0 |
| Other Non-Current Assets | $180.3B |
| TOTAL NON-CURRENT ASSETS | $347.3B |
| TOTAL ASSETS | $404.3B |
| Account Payables | $25.0B |
| Short-Term Debt | $23.2B |
| Deferred Revenue | $0 |
| Other Current Liabilities | $14.2B |
| TOTAL CURRENT LIABILITIES | $62.4B |
| Long-Term Debt | $158.5B |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $48.7B |
| Other Non-Current Liabilities | $10.0B |
| TOTAL NON-CURRENT LIABILITIES | $236.1B |
| TOTAL LIABILITIES | $298.5B |
| Common Stock | $429M |
| Additional Paid-In Capital | $13.4B |
| Retained Earnings | $94.7B |
| Treasury Stock | -$3.3B |
| Accum. Other Comp. Income | -$1.7B |
| Other Equity | $897M |
| TOTAL STOCKHOLDERS' EQUITY | $104.5B |
| Minority Interest | $1.3B |
| TOTAL EQUITY | $105.7B |
| TOTAL LIABILITIES & EQUITY | $404.3B |
| Total Debt | $200.6B |
| Net Debt | $181.5B |
